Clinical trial
Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked…
NCT00004827 · Retina Foundation of the Southwest, Other · Completed
Key facts
| NCT number | NCT00004827 |
|---|---|
| Title | Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa |
| Lead sponsor | Retina Foundation of the Southwest, Other |
| Status | Completed |
| Study type | Interventional |
| Conditions | Retinitis Pigmentosa |
| Intervention type | Drug |
| Interventions | docosahexaenoic acid |
| Enrollment | 46 |
| Start date | Mar 1, 1996 |
| Completion | Jun 1, 2002 |
| First posted | Feb 25, 2000 |
| Last update posted | Mar 25, 2015 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: